Respiratory Disease Testing Market To Reach $7.75 Billion By 2030

September 2023 | Report Format: Electronic (PDF)

Respiratory Disease Testing Market Growth & Trends

The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring.  Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.

key Request a free sample copy or view report summary: Respiratory Disease Testing Market Report

Respiratory Disease Testing Market Report Highlights

  • Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth

  • Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies

  • Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally

  • Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment

  • North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance

  • Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma

  • Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Respiratory Disease Testing Market Segmentation

Grand View Research has segmented the global respiratory disease testing market on the basis of product, application, end-use, and region:

Respiratory Disease Testing Market Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Imaging Tests

  • Respiratory Measurement Devices

  • Blood Gas Test

  • Others

Respiratory Disease Testing Market Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Chronic Obstructive Pulmonary Disease

  • Lung Cancer

  • Asthma

  • Tuberculosis

  • Other

Respiratory Disease Testing Market End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital

  • Physicians Clinic

  • Clinical Laboratories

  • Other

Respiratory Disease Testing Market Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait

List of Key Players in the Respiratory Disease Testing Market

  • Abbott

  • BD

  • Koninklijke Philips N.V.

  • ResMed

  • Fisher & Paykel Appliances Ltd.

  • Medtronic


  • Carestream Health

  • SDI Diagnostics

  • Siemens Healthcare GmbH

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.